MAP2K1 and cholangiocarcinoma: In CCA, pathway mapping shows ABCA1 (cholesterol/ABC transport) and MAP2K1 (RAF–MEK–ERK) are downregulated, while TUBB3 (gap-junction/connexin trafficking, microtubules) and FLNC (actin–focal-adhesion modules) are upregulated.